Worldwide Polycythemia Vera Treatment Market Research Report 2021 by Type, Application, Participants and Countries, Forecast Year to 2026
- PRO4358722
- 124 Pages
- March 2021
- Healthcare
Polycythemia vera a rare sort of blood cancer cells that begins in the bone marrow. polycythemia vera is taken into consideration when the hematocrit reaches greater than 48% in ladies as well as 52% in men while haemoglobin degree of higher than 16.5 g/dl in females and 18.5 g/dl in guys.
In polycythemia vera, the bone marrow creates as well lots of red cell which can result in embolism due to thickening of the blood. polycythemia vera includes following signs and symptoms such as migraine, weak point, shortness of breathing, lightheadedness, dual vision and sweating typically during the evening.
Polycythemia vera becomes worse with time if stay undiagnosed can be deadly. polycythemia vera can be treatable yet can not be curable. polycythemia vera therapy might consist of phlebotomy and also drug treatment.
Phlebotomy includes the removal of blood from the body. drug treatment involves using hydroxyurea and interferon-alfa. clients who do not react to hydroxyurea are treated with ruxolitinib(jakafi) or busulfan.
International polycythemia therapy market is raising quickly due to the rising number of instances.
In some cases a low dose of aspirin, allopurinol and antihistamines are likewise chosen for polycythemia vera treatment. givinostat is an arising medicine in polycythemia vera therapy market.
It is an orally bioavailable hydroxyl prevention of histone deacetylase with potential anti-angiogenic, antineoplastic as well as anti-inflammatory activities.another medicine ptg-300 is under trial phase. it resembles the residential or commercial properties of the natural hormone hepicidin.
Boosting prevalence of the cases is expected to drive the growth of the polycyhthemia vera therapy market. climbing recognition among individuals about the condition and a much better understanding of the condition by biotechnology markets is expected to drive the development of the polycythemia vera treatment market.
Growing ecological anxiety as a result of which direct exposure to toxic compounds is raising is anticipated to drive the development of polycythemia vera therapy market, as it may cause anomaly in the cells which is one of the primary root cause of polycythemia vera condition.
Scientists are focusing on developing brand-new treatments for treating polycythemia vera, which in turn is expected to drive the development of polycythemia vera treatment market.polycythemia vera therapy market has actually been fractional on the basis of medication class, path of administration and circulation network
The international polycythemia vera therapy market is anticipated to be dominated by antimetabolite medicine as a result of its success price on dealing with the illness as compared to various other medications in the marketplace.
It has actually come to be a drug of option as well as is expected to experience stable development over the projection duration. based on the course of management, the oral route is one of the most regularly used course of management.
Based on the distribution channel, health center drug stores are expected to be one of the most successful sector in polycythemia vera treatment market.
North America is anticipated to have the major share of the polycythemia vera treatment market due to greater frequency of the illness. north America adhered to by Europe is anticipated to be the second most lucrative region in the international polycythemia vera therapy market.
Asia-pacific is expected to be the fastest-growing polycythemia vera therapy market due to rising populace in nations like India as well as China. Latin America market is expected to experience a continuous development whereas the center east and Africa is expected to be the least profitable market because of reduced adoption of medications.
The key participants running in the global polycythemia vera treatment market are:
Pfizer inc
Galena biopharma
Bristol-myers squibb company
Novartis ag
Eli lilly and company
Pharmaessentia corporation
Bayer ag
Mylan n.v.
Teva drugs sectors ltd
Glaxosmithkline plc
The report covers extensive analysis on:
Polycythemia vera therapy market sectors
Polycythemia vera therapy market dynamics
Historic real market dimension, 2015 - 2019
Polycythemia vera therapy market dimension & forecast 2020 to 2030
Polycythemia vera treatment market current trends/issues/challenges
Competitors & business entailed
Polycythemia vera therapy market vehicle drivers and also restraints
Regional evaluation consists of
North America
Latin America
Europe
Asia pacific
Middle east & Africa
Impact of covid-19 on polycythemia vera treatment market:
During this covid-19 pandemic, pharmaceutical business, clinical tools companies and likewise biotechnology firms are facing fast difficulties that are occurring from the interruption in supply chains and the demand to transform service processes.
As the researches revealed, that there is no relationship in between blood cancer cells as well as coronavirus, polycythemia vera therapy market is being affected by this pandemic. if covid-19 pandemic proceeds for a medium/long duration, it may influence the supply of energetic product and also active ingredients around the world along with the import as well as export of drugs.
There has been a disturbance in the treatment market. as coronavirus has actually ended up being the major emphasis, all study institutes, biotech as well as pharmaceutical companies are selected in cooperation job to manage covid-19.
Report highlights:
Changing sector characteristics
Extensive market segmentation
Historic, existing and also predicted sector size current industry trends
Crucial competitors landscape
Methods for principals as well as item offerings
Possible and also specific niche segments/regions exhibiting promising growth
A neutral point of view in the direction of market efficiency
By medication class:
Antimetabolite
Kinase preventions
Alpha interferon
Discerning serotonin reuptake preventions
Others
By path of management:
Oral
Intravenous
Intramascular
Subcutaneous
By distribution network:
Health center pharmacies
Retail pharmacies
Medication store
On-line sales
1. Introduction
1.1 Definition of the Market
1.2 Research Purpose
1.3 Scope of the Study
1.4 Stakeholders
1.5 Geography Coverage
1.6 Currency Under Consideration
1.7 Volume Units
1.8 Review Cycle
1.9 Summary and Key Findings of the Research
2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach (Involves time, Space, and Persons)
2.3 Data Triangulation
2.4 Assumptions
2.5 Hypothesis of this Research, Clear, specific, and testable statement of this research
2.6 Limitations of Our Study
2.7 Scene Based Modeling
2.8 Covid-19 Impact/Evaluation
3. Market Dynamics
3.1 Driving Factors
3.1.1 Rising Demand in one or More of the Following Regions: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
3.1.2 Increasing Use of Polycythemia Vera Treatment by Different End-User/Applications
3.2 Restraints and Challenges in the Market
3.3 Opportunities
4. Global Polycythemia Vera Treatment Market-Segmentation
4.1 By Type
…
4.2 By End-User/Application Industry
…
4.3 By Geography
4.3.1 North America Polycythemia Vera Treatment Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.1.1 North America Polycythemia Vera Treatment Production from 2014-2020
4.3.1.2 North America Polycythemia Vera Treatment Consumption from 2014-2020
4.3.1.3 North America Polycythemia Vera Treatment Import and Export from 2014-2020
4.3.1.4 North America Polycythemia Vera Treatment Market Value ($) and Growth (%) by Type from 2019-2020
4.3.1.5 North America Polycythemia Vera Treatment Market Value ($) and Growth (%) by Application from 2019-2020
4.3.1.6 North America Polycythemia Vera Treatment Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.1.7 Top North America Polycythemia Vera Treatment Participants Value ($) and Market Share (%) in 2020
4.3.2 Europe Polycythemia Vera Treatment Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.2.1 Europe Polycythemia Vera Treatment Production from 2014-2020
4.3.2.2 Europe Polycythemia Vera Treatment Consumption from 2014-2020
4.3.2.3 Europe Polycythemia Vera Treatment Import and Export from 2014-2020
4.3.2.4 Europe Polycythemia Vera Treatment Market Value ($) and Growth (%) by Type from 2019-2020
4.3.2.5 Europe Polycythemia Vera Treatment Value ($) and Growth (%) by Application from 2019-2020
4.3.2.6 Europe Polycythemia Vera Treatment Market Value ($) and Growth (%) by Countries from 2019-2020
4.3.2.7 Top Europe Polycythemia Vera Treatment Participants Value ($) and Market Share (%) in 2020
4.3.3 Asia-Pacific Polycythemia Vera Treatment Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.3.1 Asia-Pacific Polycythemia Vera Treatment Production from 2014-2020
4.3.3.2 Asia-Pacific Polycythemia Vera Treatment Consumption from 2014-2020
4.3.3.3 Asia-Pacific Polycythemia Vera Treatment Import and Export from 2014-2020
4.3.3.4 Asia-Pacific Polycythemia Vera Treatment Value ($) and Growth (%) by Type from 2019-2020
4.3.3.5 Asia-Pacific Polycythemia Vera Treatment Value ($) and Growth (%) by Application from 2019-2020
4.3.3.6 Asia-Pacific Polycythemia Vera Treatment Value ($) and Growth (%) by Countries from 2019-2020
4.3.3.7 Top Asia-Pacific Polycythemia Vera Treatment Participants Value ($) and Market Share (%) in 2020
4.3.4 Latin America Polycythemia Vera Treatment Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.4.1 Latin America Polycythemia Vera Treatment Production from 2014-2020
4.3.4.2 Latin America Polycythemia Vera Treatment Consumption from 2014-2020
4.3.4.3 Latin America Polycythemia Vera Treatment Import and Export from 2014-2020
4.3.4.4 Latin America Polycythemia Vera Treatment Value ($) and Growth (%) by Type from 2019-2020
4.3.4.5 Latin America Polycythemia Vera Treatment Value ($) and Growth (%) by Application from 2019-2020
4.3.4.6 Latin America Polycythemia Vera Treatment Value ($) and Growth (%) by Countries from 2019-2020
4.3.4.7 Top Latin America Polycythemia Vera Treatment Participants Value ($) and Market Share (%) in 2020
4.3.5 Middle East & Africa Polycythemia Vera Treatment Total Market Size (Production, Consumption, Import, Export) and Segmentation (by Type, Application, Countries and Participants)
4.3.5.1 Middle East & Africa Polycythemia Vera Treatment Production from 2014-2020
4.3.5.2 Middle East & Africa Polycythemia Vera Treatment Consumption from 2014-2020
4.3.5.3 Middle East & Africa Polycythemia Vera Treatment Import and Export from 2014-2020
4.3.5.4 Middle East & Africa Polycythemia Vera Treatment Value ($) and Growth (%) by Type from 2019-2020
4.3.5.5 Middle East & Africa Polycythemia Vera Treatment Value ($) and Growth (%) by Application from 2019-2020
4.3.5.6 Middle East & Africa Polycythemia Vera Treatment Value ($) and Growth (%) by Countries from 2019-2020
4.3.5.7 Top Middle East & Africa Polycythemia Vera Treatment Participants Value ($) and Market Share (%) in 2020
5. Global Level Competitive Intelligence – Company Profiles
5.1 Company one
5.1.1 Company one Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.1.2 Company one Sales, Growth Rate and Global Market Share from 2014-2020
5.2 Company two
5.2.1 Company two Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.2.2 Company two Sales, Growth Rate and Global Market Share from 2014-2020
5.3 Company three
5.3.1 Company three Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.3.2 Company three Sales, Growth Rate and Global Market Share from 2014-2020
5.4 Company four
5.4.1 Company four Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.4.2 Company four Sales, Growth Rate and Global Market Share from 2014-2020
5.5 Company five
5.5.1 Company five Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.5.2 Company five Sales, Growth Rate and Global Market Share from 2014-2020
5.6 Company six
5.6.1 Company six Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.6.2 Company six Sales, Growth Rate and Global Market Share from 2014-2020
5.7 Company seven
5.7.1 Company seven Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.7.2 Company seven Sales, Growth Rate and Global Market Share from 2014-2020
5.8 Company eight
5.8.1 Company eight Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.8.2 Company eight Sales, Growth Rate and Global Market Share from 2014-2020
5.9 Company nine
5.9.1 Company nine Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.9.2 Company nine Sales, Growth Rate and Global Market Share from 2014-2020
5.10 Company ten
5.10.1 Company ten Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.10.2 Company ten Sales, Growth Rate and Global Market Share from 2014-2020
5.11 Company 11
5.11.1 Company 11 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.11.2 Company 11 Sales, Growth Rate and Global Market Share from 2014-2020
5.12 Company 12
5.12.1 Company 12 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.12.2 Company 12 Sales, Growth Rate and Global Market Share from 2014-2020
5.13 Company 13
5.13.1 Company 13 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.13.2 Company 13 Sales, Growth Rate and Global Market Share from 2014-2020
5.14 Company 14
5.14.1 Company 14 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.14.2 Company 14 Sales, Growth Rate and Global Market Share from 2014-2020
5.15 Company 15
5.15.1 Company 15 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
5.15.2 Company 15 Sales, Growth Rate and Global Market Share from 2014-2020
...
6. Investment Analysis
6.1 Fundamental Analysis (Porter's Five Forces Analysis)
6.2 Technical Preparation Analysis
6.3 Risk Evaluating Analysis
6.4 Estimated Investment Pay-Back Period
7. Future Forecast of Global Polycythemia Vera Treatment Market from 2020-2026
7.1 Future Forecast of Global Polycythemia Vera Treatment Market from 2020-2026 Segment by Regions
7.2 Future Forecast of Global Polycythemia Vera Treatment Market from 2020-2026 Segment by Type
7.3 Future Forecast of Global Polycythemia Vera Treatment Market from 2020-2026 Segment by Application
8 Appendix
8.1 Discussion Guide
8.2 Related Reports
8.3 Author List
849 Disclaimer
Table Key Data from Secondary Sources
Table Key Data Parameter
Figure Market Size Estimation by End-Use Industry
Figure Market: Data Triangulation
Figure Market Size Estimation: Top-Down Approach
Table Driving Factors for this Market (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa)
Table Global Polycythemia Vera Treatment Production and Growth Rate Segment by Product Types from 2014-2020
Table Global Polycythemia Vera Treatment Value ($) and Growth Rate Segment by Product Types from 2014-2020
Figure Type 1 of Polycythemia Vera Treatment
Figure Type 2 of Polycythemia Vera Treatment
Figure Type 3 of Polycythemia Vera Treatment
Table Global Polycythemia Vera Treatment Consumption and Growth Rate Segment by End-User/Application from 2014-2020
Table Global Polycythemia Vera Treatment Value ($) and Growth Rate Segment by End-User/Application from 2014-2020
Figure Application 1 of Polycythemia Vera Treatment
Figure Application 2 of Polycythemia Vera Treatment
Figure Application 3 of Polycythemia Vera Treatment
Table Global Polycythemia Vera Treatment Production Value ($) by Regions
Table Global Polycythemia Vera Treatment Production Value Share by Regions
Table Global Polycythemia Vera Treatment Production by Regions
Table Global Polycythemia Vera Treatment Production Share by Regions
Table Global Polycythemia Vera Treatment Consumption by Regions
Table Global Polycythemia Vera Treatment Consumption Share by Regions
Figure North America Polycythemia Vera Treatment Production and Growth Rate from 2014-2020
Figure North America Polycythemia Vera Treatment Consumption and Growth Rate from 2014-2020
Table North America Polycythemia Vera Treatment Import and Export from 2014-2020
Table North America Polycythemia Vera Treatment Value ($) and Growth (%) by Type from 2019-2020
Table North America Polycythemia Vera Treatment Value ($) and Growth (%) by Application from 2019-2020
Table North America Polycythemia Vera Treatment Value ($) and Growth (%) by Countries from 2019-2020
Table Top North America Polycythemia Vera Treatment Participants Value ($) and Market Share (%) in 2020
Figure Europe Polycythemia Vera Treatment Production and Growth Rate from 2014-2020
Figure Europe Polycythemia Vera Treatment Consumption and Growth Rate from 2014-2020
Table Europe Polycythemia Vera Treatment Import and Export from 2014-2020
Table Europe Polycythemia Vera Treatment Value ($) and Growth (%) by Type from 2019-2020
Table Europe Polycythemia Vera Treatment Value ($) and Growth (%) by Application from 2019-2020
Table Europe Polycythemia Vera Treatment Market Value ($) and Growth (%) by Countries from 2019-2020
Table Top Europe Polycythemia Vera Treatment Participants Value ($) and Market Share (%) in 2020
Figure Asia-Pacific Polycythemia Vera Treatment Production and Growth Rate from 2014-2020
Figure Asia-Pacific Polycythemia Vera Treatment Consumption and Growth Rate from 2014-2020
Table Asia-Pacific Polycythemia Vera Treatment Import and Export from 2014-2020
Table Asia-Pacific Polycythemia Vera Treatment Value ($) and Growth (%) by Type from 2019-2020
Table Asia-Pacific Polycythemia Vera Treatment Value ($) and Growth (%) by Application from 2019-2020
Table Asia-Pacific Polycythemia Vera Treatment Value ($) and Growth (%) by Countries from 2019-2020
Table Top Asia-Pacific Polycythemia Vera Treatment Participants Value ($) and Market Share (%) in 2020
Figure Latin America Polycythemia Vera Treatment Production and Growth Rate from 2014-2020
Figure Latin America Polycythemia Vera Treatment Consumption and Growth Rate from 2014-2020
Table Latin America Polycythemia Vera Treatment Import and Export from 2014-2020
Table Latin America Polycythemia Vera Treatment Value ($) and Growth (%) by Type from 2019-2020
Table Latin America Polycythemia Vera Treatment Value ($) and Growth (%) by Application from 2019-2020
Table Latin America Polycythemia Vera Treatment Value ($) and Growth (%) by Countries from 2019-2020
Table Top Latin America Polycythemia Vera Treatment Participants Value ($) and Market Share (%) in 2020
Figure Middle East & Africa Polycythemia Vera Treatment Production and Growth Rate from 2014-2020
Figure Middle East & Africa Polycythemia Vera Treatment Consumption and Growth Rate from 2014-2020
Table Middle East & Africa Polycythemia Vera Treatment Import and Export from 2014-2020
Table Middle East & Africa Polycythemia Vera Treatment Value ($) and Growth (%) by Type from 2019-2020
Table Middle East & Africa Polycythemia Vera Treatment Value ($) and Growth (%) by Application from 2019-2020
Table Middle East & Africa Polycythemia Vera Treatment Value ($) and Growth (%) by Countries from 2019-2020
Table Top Middle East & Africa Polycythemia Vera Treatment Participants Value ($) and Market Share (%) in 2020
Table Company one Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company one Sales and Growth Rate from 2014-2020
Figure Company one Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company two Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company two Sales and Growth Rate from 2014-2020
Figure Company two Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company three Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company three Sales and Growth Rate from 2014-2020
Figure Company three Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company four Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company four Sales and Growth Rate from 2014-2020
Figure Company four Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company five Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company five Sales and Growth Rate from 2014-2020
Figure Company five Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company six Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company six Sales and Growth Rate from 2014-2020
Figure Company six Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company seven Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company seven Sales and Growth Rate from 2014-2020
Figure Company seven Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company eight Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company eight Sales and Growth Rate from 2014-2020
Figure Company eight Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company nine Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company nine Sales and Growth Rate from 2014-2020
Figure Company nine Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company ten Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company ten Sales and Growth Rate from 2014-2020
Figure Company ten Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 11 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 11 Sales and Growth Rate from 2014-2020
Figure Company 11 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 12 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 12 Sales and Growth Rate from 2014-2020
Figure Company 12 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 13 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 13 Sales and Growth Rate from 2014-2020
Figure Company 13 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 14 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 14 Sales and Growth Rate from 2014-2020
Figure Company 14 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Company 15 Company Profile (Company Name, Major Business, Plants Distribution, Sales Region, Contact Information)
Figure Company 15 Sales and Growth Rate from 2014-2020
Figure Company 15 Revenue ($), Gross Margin and Global Market Share from 2014-2020
Table Global Polycythemia Vera Treatment Value ($) and Growth Rate Forecast by Regions (2020-2026)
Table Global Polycythemia Vera Treatment Production and Growth Rate Forecast by Regions (2020-2026)
Table Global Polycythemia Vera Treatment Consumption and Growth Rate Forecast by Regions (2020-2026)
Table Global Polycythemia Vera Treatment Production and Growth Rate Forecast by Types (2020-2026)
Table Global Polycythemia Vera Treatment Consumption and Growth Rate Forecast by End-User/Applications (2020-2866)
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
